BIOMAT Database Logo BIOMAT Database Logo

Beta-Adrenergic blocking agents. V. 1-Amino-3-(substituted phenoxy)-2-propanols. 1969

A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D000605 Amino Alcohols Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2). Alcohols, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents
D013610 Tachycardia Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. Tachyarrhythmia,Tachyarrhythmias,Tachycardias

Related Publications

A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols.
November 1982, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
December 1977, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Beta-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols.
May 1977, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
September 1978, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
March 1983, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
February 1975, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols.
October 1977, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Beta-adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols.
September 1968, Journal of medicinal chemistry,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Quantitative structure-activity relationship in 1-substituted ureidophenoxy-3-amino-2-propanols, a class of beta-adrenergic blocking agents.
January 1980, Arzneimittel-Forschung,
A F Crowther, and D J Gilman, and B J McLoughlin, and L H Smith, and R W Turner, and T M Wood
Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
July 1986, Arzneimittel-Forschung,
Copied contents to your clipboard!